| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/14/2013 | CN103249729A Anthranilic acid diamide derivatives with cyclical side chains |
| 08/14/2013 | CN103242304A Synthetic method of anti-inflammatory drug tenidap sodium |
| 08/14/2013 | CN101906095B Thioxathone-4-carboxylic ester and preparation method as well as photoinitiator composition and application |
| 08/14/2013 | CN101730689B pigmentation-regulator compound |
| 08/14/2013 | CN101331124B Novel vanilloid receptor ligands and their use for producing medicaments |
| 08/13/2013 | CA2738878C Selective estrogen receptor modulator for the treatment of osteoarthritis |
| 08/13/2013 | CA2619566C 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2619448C 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/08/2013 | WO2013116230A1 Dihydrofuran azetidine derivatives as antiparasitic agents |
| 08/08/2013 | WO2013116182A1 Heterocyclic compounds as inhibitors of leukotriene production |
| 08/08/2013 | WO2013114403A1 Substituted 4,5-dihydro-2h-benzo[e]indazole-9-carboxylates for the treatment of diabetes and related disorders |
| 08/08/2013 | US20130203987 Ampk-activating heterocyclic compounds and methods for using the same |
| 08/08/2013 | US20130203819 Apoptosis signal-regulating kinase inhibitors |
| 08/08/2013 | US20130203818 Compounds that modulate intracellular calcium |
| 08/08/2013 | US20130203815 Cytokine inhibitors |
| 08/08/2013 | US20130203750 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 08/08/2013 | US20130203749 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 08/08/2013 | US20130200359 Triphenylene-based materials for organic electroluminescent devices |
| 08/07/2013 | EP2621923A1 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases |
| 08/07/2013 | EP2621918A1 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
| 08/07/2013 | CN103237794A P2X4 receptor antagonist |
| 08/07/2013 | CN103237792A Rare earth metal complex |
| 08/07/2013 | CN103232843A Electroluminescent material and application thereof |
| 08/07/2013 | CN103232419A Multi-ingredient one pot synthesis method of 2-aromatic methylideneamino-3-aryl-4-hydroxy coumarone derivative |
| 08/07/2013 | CN103230389A Novel nitrocatechol derivatives having selectin ligand activity |
| 08/06/2013 | US8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 08/06/2013 | US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 08/06/2013 | US8501773 4-fluoro-piperidine T-type calcium channel antagonists |
| 08/06/2013 | US8501740 Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 08/06/2013 | CA2588513C 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/01/2013 | WO2013111107A1 Aminopyridine derivatives as plasma kallikrein inhibitors |
| 08/01/2013 | WO2013055417A3 Thiophene based oligomers as light activated biocides |
| 08/01/2013 | US20130197221 Benzimidazole Derivatives As PI3 Kinase Inhibitors |
| 08/01/2013 | US20130197013 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 08/01/2013 | US20130196990 Benzimidazole Derivatives As PI3 Kinase Inhibitors |
| 08/01/2013 | US20130196967 Heterocyclic compounds as inhibitors of leukotriene production |
| 08/01/2013 | US20130196952 Heterocyclic derivatives for the treatment of diseases |
| 07/31/2013 | EP2620435A1 Phenyl and benzodioxinyl substituted indazole derivatives |
| 07/31/2013 | EP2620429A1 Hydroxylamine compounds and methods of their use |
| 07/31/2013 | EP2619185A1 Matrix metalloproteinase inhibitors |
| 07/31/2013 | EP2619178A1 Substituted benzamide compounds |
| 07/31/2013 | CN103228637A Method for producing optically active fluorine-containing oxeten |
| 07/31/2013 | CN103228634A Matrix metalloproteinase inhibitors |
| 07/31/2013 | CN103228141A Substituted fused pyrimidinones and dihydropyrimidinones |
| 07/31/2013 | CN103225083A Application of acethydrazide type compound containing thiophene heterocycle and being used as corrosion inhibitor |
| 07/31/2013 | CN101863883B Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof |
| 07/30/2013 | US8497271 Modulators of G protein-coupled receptor 88 |
| 07/30/2013 | CA2659549C Compositions and methods relating to novel compounds and targets thereof |
| 07/30/2013 | CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/30/2013 | CA2561305C Tetrahydro-indazole cannabinoid modulators |
| 07/25/2013 | WO2013109118A1 Method for preparing thioepoxy-based optical material and polymerizable composition thereof |
| 07/25/2013 | WO2013109045A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/25/2013 | WO2013108857A1 Heterocyclic amide derivative and pharmaceutical product containing same |
| 07/25/2013 | WO2013107278A1 New-type anti-cancer compounds synthesized from reaction of ketone and indole derivatives |
| 07/25/2013 | US20130190489 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof |
| 07/25/2013 | US20130190356 Benzyl sulfonamide derivatives as rorc modulators |
| 07/25/2013 | US20130190355 Dual inhibitors of farnesyltransferase and geranylgeranyltransferase i |
| 07/25/2013 | US20130190330 Bisaryl-bonded aryltriazolones and use thereof |
| 07/25/2013 | US20130190302 Modulators of amyloid beta |
| 07/25/2013 | US20130190289 Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/25/2013 | US20130188270 Oxime ester |
| 07/24/2013 | EP2616464A2 Improved process for the preparation of sufentanil base and related compounds |
| 07/24/2013 | EP2616462A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
| 07/24/2013 | EP2616459A1 Pyridine compounds for controlling invertebrate pests i |
| 07/24/2013 | EP2616450A2 Sulfonamide compounds |
| 07/24/2013 | EP2616448A1 Substituted phenylacetate and phenylpropane amides and use thereof |
| 07/24/2013 | EP2616445A2 Estrogen receptor modulators and uses thereof |
| 07/24/2013 | EP2616443A1 Phtalazine derivatives as jak1 inhibitors |
| 07/24/2013 | CN1989122B Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 07/24/2013 | CN1863800B Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/24/2013 | CN103221406A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221403A Heterocyclic compounds and their uses |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103221397A New compositions and methods for controlling nematode pests |
| 07/24/2013 | CN103214472A Preparation of two novel non-ATP (Adenosine Triphosphate) competitive FGFR1 (Fibroblast Growth Factor Receptor1) inhibitors and anti-tumor activity of two novel non-ATP competitive FGFR1 inhibitors |
| 07/24/2013 | CN103214471A Novel compound |
| 07/24/2013 | CN103214470A Novel anticancer compound synthesized by reaction of ketone and indole derivative |
| 07/24/2013 | CN103214464A Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214412A Polycyclic derivative with chiral spiral oxoindole structure segment and synthetic method of polycyclic derivative |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 07/24/2013 | CN101730684B Sulfonyl-quinoline derivatives |
| 07/24/2013 | CN101570504B Novel compounds for electronic material and organic electronic device using the same |
| 07/24/2013 | CN101560186B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101258131B 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 07/23/2013 | US8492564 Salvinorin derivatives and uses thereof |
| 07/23/2013 | US8492563 4,5,6,7-tetrahydrobenzo[B]thiophene derivatives and their use as sigma receptor ligands |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492407 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 07/23/2013 | US8492111 Arylalkylamine compound and process for preparing the same |
| 07/23/2013 | CA2616396C Growth hormone secretagogues |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2583967C 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |